DELCATH SYSTEMS INC | 0,299 Euro | -0,005 -1,64 % | |
| WKN: 565819 ISIN: US24661P1049 Ticker-Symbol: DV3 | Stuttgart | 24.05.13 | 08:01 Uhr |
Branche GesundheitswesenAktienmarkt Sonstige |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 23.05. | Delcath shareholders negative on CEO pay | 5 | bizjournals | |
| 18.05. | Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm | 76 | PR Newswire | |
| NEW YORK, May 18, 2013 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Delcath Systems, Inc. ("Delcath" or the "Company")... Mehr lesen zu: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm | ||||
| 17.05. | DELCATH SYSTEMS, INC. - 8-K, Current Report | - | SEC Filings | |
| 17.05. | Delcath facing lawsuits in wake of stock drop | 1 | bizjournals | |
| 14.05. | Delcath Systems has the Lowest Sales per Share in the Health Care Equipment Industry | 3 | SmarTrend | |
| 11.05. | Delcath Systems, Inc. Sued by Investor | 81 | PR Newswire | |
| SAN DIEGO and NEW YORK, May 10, 2013 /PRNewswire/ --Shareholder rights attorneys at Robbins Arroyo LLP announce that a shareholder of Delcath Systems, Inc. (NASDAQ: DCTH) filed a federal securities... Mehr lesen zu: Delcath Systems, Inc. Sued by Investor | ||||
| 10.05. | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Delcath Systems, Inc. (NASDAQ: DCTH) | 59 | Marketwired | |
| OKLAHOMA CITY, OK -- (Marketwired) -- 05/10/13 -- On May 8, 2013, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Delcath Systems... Mehr lesen zu: Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Delcath Systems, Inc. (NASDAQ: DCTH) | ||||
| 09.05. | DELCATH SYSTEMS, INC. - 10-Q, Quaterly Report | 1 | SEC Filings | |
| 09.05. | Delcath to spend at least $14 million on global clinical trial | 5 | bizjournals | |
| 09.05. | Delcath Systems Management Discusses Q1 2013 Results - Earnings Call Transcript | 3 | Seeking Alpha | |
| 08.05. | Lowest Revenue Per Employee in the Health Care Equipment Industry Detected in Shares of Delcath Systems | 1 | SmarTrend | |
| 06.05. | The ODAC Postmortem: Lessons Learned Part 2, Delcath Systems | 5 | Seeking Alpha | |
| 03.05. | Investors look to Lighten Up on Shares of Delcath Systems, Shares Down 39.0% | 12 | SmarTrend | |
| 03.05. | Delcath stock drop brings out the lawyers | 7 | bizjournals | |
| 03.05. | Downgrade Alert for Delcath Systems | 8 | SmarTrend | |
| 03.05. | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Delcath Systems, Inc. | 32 | PR Newswire | |
| NEW YORK, May 3, 2013 /PRNewswire/ --Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Delcath Systems, Inc.... Mehr lesen zu: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Delcath Systems, Inc. | ||||
| 03.05. | FDA advised to reject Delcath's chemo system | 5 | bizjournals | |
| 03.05. | XFRA DV3: WIEDERAUFNAHME/RESTART | 23 | Xetra Newsboard | |
| DIE FOLGENDE AKTIE WIRD MIT SOFORTIGER WIRKUNG WIEDER IN DEN HANDEL
AUFGENOMMEN:
THE FOLLOWING SHARE IS RESUMED TRADING WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
DELCATH SYS... Mehr lesen zu: XFRA DV3: WIEDERAUFNAHME/RESTART | ||||
| 03.05. | UPDATE 2-FDA advisers recommend against Delcath's cancer therapy | 5 | Reuters.com | |
| 03.05. | Delcath Confirms FDA Panel Voted 16-0 Against Benefits of Melblez Kit | 5 | Benzinga.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| NEKTAR THERAPEUTICS | 7,164 | +0,92 % | Nektar Therapeutics' CEO Presents at UBS Global Healthcare Conference (Transcript) |
| CELSION | 0,805 | +9,38 % | Celsion Announces Issuance of Additional Patents Covering ThermoDox Technologies |
| GEMOSCAN CANADA | 0,086 | +3,61 % | Gemoscan Announces Revision to Shares for Service Submissions |
| MEDICAL MARIJUANA | - | - | Medical Marijuana Inc.: Medical Marijuana Inc., Posts 1st Quarter Audited Financial and Disclosure Statements; Net Income Exceeds Quarterly Projections |
| MOBILLER COMMUNICATIONS | 1,603 | -13,12 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-003 |
